ERBB2 SUPPRESSION DECREASES CELL GROWTH VIA APOPTOSIS IN GASTROINTESTINAL ADENOCARCINOMAS

While the incidence of esophageal and GE junction adenocarcinomas have increased at an alarming rate in the past 30 years, little improvement has been made in treatment strategies. Previous studies have shown that many upper gastrointestinal adenocarcinomas exhibit ERBB2 amplification. In cancers pr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Surgery
Egile Nagusiak: Arrington, A. K., Dahlberg, P. S., Davydova, J., Vickers, S. M., Yamamoto, M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4569097/
https://ncbi.nlm.nih.gov/pubmed/19628076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2009.04.008
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak